Inventor · disambiguated record
Hee Lam Chan
Also filed as: CHAN HEE LAM
7 granted patents·2 pending applications·8 citations·filing 2016–2021
78Inventor score
Files withPROQR THERAPEUTICS II BV9
Top patents by PatentIndex Score
9 records- 0183US10617707B2Oligonucleotides to treat eye diseasePROQR THERAPEUTICS II BV·Filed 2017·Granted Apr 14, 2020·2 cites·15 claims
- 0282US10612025B2Antisense oligonucleotides for the treatment of eye diseasePROQR THERAPEUTICS II BV·Filed 2017·Granted Apr 7, 2020·2 cites·11 claims
- 0380US11123360B2Oligonucleotides to treat eye diseasePROQR THERAPEUTICS II BV·Filed 2020·Granted Sep 21, 2021·1 cites·17 claims
- 0477US10889817B2Oligonucleotide therapy for Leber Congenital AmaurosisPROQR THERAPEUTICS II BV·Filed 2019·Granted Jan 12, 2021·1 cites·6 claims
- 0574US10421963B2Oligonucleotide therapy for leber congenital amaurosisPROQR THERAPEUTICS II BV·Filed 2016·Granted Sep 24, 2019·2 cites·14 claims
- 0668US11920132B2Oligonucleotide therapy for Leber congenital amaurosisPROQR THERAPEUTICS II BV·Filed 2021·Granted Mar 5, 2024·0 cites·2 claims
- 0768US2021401871A1Oligonucleotides to treat eye diseasePROQR THERAPEUTICS II BV·Filed 2021·Application pending·0 cites
- 0864US11479771B2Antisense oligonucleotides for the treatment of eye diseasePROQR THERAPEUTICS II BV·Filed 2020·Granted Oct 25, 2022·0 cites·16 claims
- 0944US2022213478A1Antisense oligonucleotides for the treatment of usher syndromePROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hee Lam Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →